<code id='AFDAEFCE75'></code><style id='AFDAEFCE75'></style>
    • <acronym id='AFDAEFCE75'></acronym>
      <center id='AFDAEFCE75'><center id='AFDAEFCE75'><tfoot id='AFDAEFCE75'></tfoot></center><abbr id='AFDAEFCE75'><dir id='AFDAEFCE75'><tfoot id='AFDAEFCE75'></tfoot><noframes id='AFDAEFCE75'>

    • <optgroup id='AFDAEFCE75'><strike id='AFDAEFCE75'><sup id='AFDAEFCE75'></sup></strike><code id='AFDAEFCE75'></code></optgroup>
        1. <b id='AFDAEFCE75'><label id='AFDAEFCE75'><select id='AFDAEFCE75'><dt id='AFDAEFCE75'><span id='AFDAEFCE75'></span></dt></select></label></b><u id='AFDAEFCE75'></u>
          <i id='AFDAEFCE75'><strike id='AFDAEFCE75'><tt id='AFDAEFCE75'><pre id='AFDAEFCE75'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:focus    Page View:76
          Bristol Myers Squibb sign
          Courtesy Bristol Myers Squibb

          Bristol Myers Squibb will pay $4.1 billion for RayzeBio, the companies said Tuesday, buying into the fast-growing field of using targeted doses of radiation to treat cancer.

          RayzeBio, which raised about $350 million in a September initial public offering, is working in radiopharmaceuticals, which pair the tumor-killing power of radiation with the precision of targeted cancer therapies. The company is currently running a pivotal trial of its most advanced drug, RYZ101, in neuroendocrine cancer and has a pipeline of treatments for kidney, liver, and other cancers.

          advertisement

          Bristol Myers will pay $62.50 in cash per share of RayzeBio, a roughly 115% premium to the company’s recent trading and more than triple the company’s IPO price.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          In age of alternative facts, a scholarly course on calling out crap
          In age of alternative facts, a scholarly course on calling out crap

          Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

          read more
          Grad students accuse University of California of wage theft
          Grad students accuse University of California of wage theft

          UCSanDiegostudentsprotestedatanalumnieventinMay,wheretheyaccuseduniversityleadershipofwagetheft.Cour

          read more
          Apple is now the first public company to be valued at $3 trillion
          Apple is now the first public company to be valued at $3 trillion

          6:09FILE-AnApplelogoadornsthefacadeofthedowntownBrooklynApplestoreonMarch14,2020,inNewYork.Applebeca

          read more

          Why Sanofi got shellacked over its spinoff

          KristofferTripplaar/SipaviaAPImagesSanofi,theParis-baseddruggiant,announcedFridaythatitwouldspinouti